With more than 25 years in industry, Dr. Christoph Rehfuess is Head of IP at SOTIO Biotech a.s. headquartered in Prague, Czech Republic, an international biotechnology company with facilities in Europe and the U.S. developing next generation immunotherapies for patients with cancer.  SOTIO is also leading the efforts of PPF Group to build a diverse biotechnology portfolio through collaborations, in-licensing, investments, and M&A.  With a scientific background in molecular biology, he has extensive industry experience in patenting, trademarks, oppositions, German and Czech Inventors law, licensing, research and development cooperations, M&A and partnering on a broad variety projects, among others, in the fields of cytokines, ADCs, CAR-Ts, antibodies, vaccines, small molecules, botanicals, liposomes and nanoparticles.